30
Mar 2026
Armed conflict in Colombia significantly impacts tuberculosis incidence and mortality rates
The prolonged armed conflict in Colombia has had a significant impact on tuberculosis (TB) incidence and mortality.
Stay Informed!
30
Mar 2026
New clinical guideline adopts holistic approach to brain and heart health
A new brain–heart clinical practice guideline takes a holistic approach, integrating neurologic and mental health evidence with guidance for cardiovascular disease as many brain and heart conditions overlap and share similar risk factors.
30
Mar 2026
Study: Autism risk genes are largely consistent across different human ancestries
A new study, co-led by researchers at the Icahn School of Medicine at Mount Sinai and published March 30 in Nature Medicine [https://doi.org/ 10.1038/s41591-026-04228-6], demonstrates that genes associated with autism risk are largely the same across people of different ancestries.
30
Mar 2026
Mount Sinai researchers identify a highly prevalent recessive neurodevelopmental disorder
Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that appears to be the most prevalent ever discovered.
30
Mar 2026
Study opens the door for future treatments for Sleeping Sickness
To survive in the human bloodstream, the African trypanosome parasite wears a "cloak" made of proteins known as a variant surface glycoprotein (VSG).
30
Mar 2026
CFHR1 could be a new diagnostic marker for IgA nephropathy
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial cell proliferation, enhanced extracellular matrix production, and variable infiltration of inflammatory cells.
30
Mar 2026
Probiotic therapy may offer a simple strategy to help prevent premature births
Preterm birth is a major cause of neonatal illness and death, especially among women with a history of premature delivery.
30
Mar 2026
NOX-1 identified as key molecular target to prolong ketamine's antidepressant effects
Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief, its antidepressant effects fade within a few weeks.
30
Mar 2026
Benefits from food fortification, yet global nutrient gaps persist
While food fortification reduces micronutrient inadequacies, additional interventions are necessary to ensure balanced nutrition and prevent excess intake.
30
Mar 2026
Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production
Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs).
